RE:The Future of Dermatology – Exploring Virtual CareMedX has a long relationship with the MNC and has been awarded the Corporate Citezenship Award from the MNC.
https://www.businesswire.com/news/home/20180213006619/en/MedX-Receives-Corporate-Citizenship-Award-from-the-Melanoma-Network-of-Canada
The MNC runs these types of events all the time.
Lets look at DermCafe;
https://www.dermcafecanada.com/referral
They are a simply a telemedicine call with a Dermatologist. This is not the future of Dermatology but it is a catchy title. Notice they cannot treat pigmented lesions. The ones that can kill you. This technology is not in the same catagory as MedX's technology which can send images to a Dermatologist and they can assess pigmented lesions.
MedX is a fully, scalable global leader in teledermatology. MedX works to find global distributors that can deploys its offering across large networks. I understand that this story has been out there a while with little evidence of succes except, the Netherlands,Brazil,Empower (Rexall) but I still maintain MedX will deliver on its promise to become the leader in teledermatology.
The commentary regarding the recent $500,000 financing needs soom clarification. This was not a new financing there was a $500,000 note that had matured. It was related to a member of the BoD The note was @ 8% interest. The BoD member simply could have asked for the repayment of the note instead the note was reissued at 6% for another 3 years on the same terms as the most recent convertible note.
To correct another poster on this site MedX commented that its should see a strong pick up in revenue in Q3-4 not Q1. This stock has some very solid investors that understand the companies mandate and support it fully. So those with patients will be well rewarded in my opinion.
By the way Investor Relations can be reached at 416 837 7147 Bill Mitoulas. They always answer their calls so for those who suggest they have called numerous times without a response I would suggest you check the number you dialed.